Best Lymph Node Biopsy or Excision Doctors in Elmhurst, NY

Benjamin Samstein, MD is Chief of Liver Transplantation and Hepatobiliary Surgery in the Department of Surgery at NewYork-Presbyterian/Weill Cornell Medicine and Associate Professor of Surgery at Weill Cornell Medical College, Cornell University. Dr. Samstein is the Surgical Director of the Living Donor Liver Transplant Program at NYP. Dr. Samstein is a renowned pioneer in minimally invasive liver surgery and state-of-the-art laparoscopic techniques for liver cancer. Dr. Samstein is a Castle Connolly Top Doctor. Dr. Samstein heads up the multidisciplinary liver transplantation and hepatobiliary surgery team at NYP/Weill Cornell. His specialties include the most advanced laparoscopic procedures for liver cancer, benign liver tumors and hepatobiliary pancreatic disease. He has been invited to talk about minimally invasive liver surgery throughout the world. He is a member of many surgical societies including a founding member of the International Laparoscopic Liver Society (ILLS), American Society of Transplant Surgery, American Hepato-Pancreato-Biliary Association (AHPBA). He is the Chair of the Medical Advisory Board of LiveOnNY and served as the Regional representation to the Liver and Intestine Committee of UNOS from 2014 to 2016. Dr. Samstein is well-published in the field, authoring more than 40 peer-reviewed articles in prestigious medical and surgical journals, books and book chapters. Other areas of clinical expertise include hepatic adenoma, hepatic hemangioma, cholangiocarcinoma, colorectal metastasis, live donor nephrectomy, laparoscopic living donor nephrectomy, and pediatric liver and organ transplant. Dr. Samstein received his undergraduate degree from Cornell University in 1992 and earned his MD at the State University of New York at Stonybrook in 1997. He did his internship and residency in general surgery at NYP/Columbia, and completed a research fellowship at the Mayo Clinic in 2001. He completed a fellowship in ASTS Multi-organ transplant at NYP/Columbia in 2006. He was Assistant Professor of Surgery at Columbia University Medical Center from 2006 to 2015. He served as Program Director of the transplant surgery fellowship at Columbia University from 2007 to 2015. He is a reviewer for American Journal of Transplantation, Transplantation, Liver Transplantation, Pediatric Transplantation, Clinical Transplantation among other journals. List of Publications by Dr. Samstein PubMed

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Click here to view New York Times article on Dr. Michelassi's strictureplasty for crohns disease.

I am a surgeon who specializes in nerve-sparing radical prostatectomy for the treatment of prostate cancer, and 'salvage' radical prostatectomy in patients with prostate cancer in whom radiation therapy has failed. My clinical research focuses on improving outcomes (such as cancer control, urinary continence, and sexual function) following surgery for prostate cancer. Together with my colleagues in medical oncology and radiation oncology, we attempt to tailor therapy more accurately to each individual's cancer in order to control cancer spread and decrease treatment-related side effects.

My goals are to educate you and your family about your problem and fully explain the operative and non-operative options you have to treat your condition. I am always available to my patients and our team works tirelessly to keep access and the lines of communication open. Being presented with the diagnosis of a brain tumor can be stressful, and we work hard to ensure your time with us is useful, educational, and compassionate.

Anton George Kelly, MD is an Assistant Professor of Surgery in the division of Trauma, Burns, Critical and Acute Care at Weill Cornell Medical College and Assistant Attending Surgeon at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Kelly specializes in Surgical Critical Care, Acute Care Surgery and Trauma with a focus on Traumatology and Burn management.Prior to his arrival, Dr. Kelly completed his residency in general surgery at Easton Hospital in Easton Pennsylvania followed by a dual fellowship in burn surgery and surgical critical care at New York-Presbyterian/Weill Cornell Medical Center and Westchester Medical Center respectively.Dr. Kelly is an active member of many prestigious medical and surgical societies, including the American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Critical Care Medicine and the American Burn Association. He has also been published numerous peer-reviewed journal articles and abstracts.In addition, Dr. Kelly has been honored with the 2015 Physician of the Year Award from NewYork-Presbyterian/Weill Cornell Medical Center.

David Otterburn, MD, FACS, is a Professor of Surgery in the Division of Plastic and Reconstructive Surgery in the Department of Surgery at Weill Cornell Medical College. He is an Attending Surgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and is the Program Director for the Weill Cornell Medicine and Columbia University Medical Center Combined Plastic Surgery Residency Program of NYPH.Dr Otterburn is the Director of Breast Reconstruction at Weill Cornell Medicine and started the DIEP reconstruction program at Weill Cornell in 2011 and has performed over 1000 DIEP reconstructions. He has pioneered techniques to maximize the safety and efficacy of this surgery which include methods to increase aesthetic outcome, increase sensory return, improve anesthesia delivery while decreasing narcotic use after surgery and decrease overall complications during this complex surgery. He has performed innervation of DIEP flaps since 2011 and was an early adaptor in the use of nerve grafts in breast reconstruction.He has also pioneered the drainless approach to breast implant-based breast reconstruction as he recognized external drains to be one of the greatest concerns for our patients. In doing so he has significantly lowered the complication rates and postoperative pain levels for these procedures. He also uses indwelling antibiotic delivery systems which significantly decrease the risk of infection following mastectomies. He is a requested speaker at both national and international meetings on these and other topics and has an active laboratory which has published over 100 papers on these and other subjects. He has been awarded several grants for his research including from the NIH and has won awards both nationally and internationally, at many of the major plastic surgery meetings.Dr. Otterburn completed board certification in both Plastic and General Surgery. He has additional training and specialization in microvascular surgery for complex reconstructions throughout the body, utilizing 3-D imaging and other state-of-the-art technologies to obtain optimal outcomes. A special focus includes innervated microvascular breast reconstruction with perforator flaps from the abdomen (DIEP), buttocks (SGAP, IGAP) and thigh (PAP) and studying sensory return in the breast with nerve grafting techniques in both implant and flap reconstructions. He also performs soft tissue reconstruction with osteointegrated implant reconstruction for amputees and targeted muscle reinnervation and regenerative peripheral nerve interfaces to decrease nerve pain. His surgical expertise also includes oculoplastic reconstruction and reconstruction following Mohs surgery.Dr. Otterburn offers his patients aesthetic surgery of the face and body. This included botox, fillers and more invasive surgeries such as face lifts, neck lifts and blepharoplasties. He performs body contouring including liposuction, abdominoplasties, circumferential body lifts, thigh lifts, breast augmentations and breast lifts. His aesthetic goals are tailored to the individual patient, but is looking to provide you with a natural, seamless aesthetic result.

I am a surgical breast oncologist and am dedicated to helping patients fight breast cancer. This effort requires a team approach involving the expertise of multiple cancer specialists as well as the perspectives of the individual patient and her/his support network. We have made exciting advances in breast cancer management resulting in successful outcomes for the majority of our patients, but ongoing progress is necessary. Working together, we can provide more options to our patients and improve access to highest-quality, personalized care throughout metropolitan New York.

Jeffrey Milsom, MD, FACS, has unique expertise and unparalleled experience in minimally invasive surgery for complex colorectal diseases.Dr. Milsom is the lead inventor of the endoluminal surgical platform, commercially known as the DiLumen, which stabilizes the colon to allow for endoscopic procedures of greater complexity, thereby avoiding surgery for some patients.He has performed close to 2,000 laparoscopic colon and rectal operations, and has been invited to perform surgeries in over 15 countries. Under Dr. Milsom's leadership, 90 percent of all procedures in the Colon and Rectal Section at New York Presbyterian-Weill Cornell Medical Center are now performed using high-tech, minimally invasive technologies. He has published four books, 24 book chapters and over 250 papers, presentations and educational videos.He is a member of 14 prestigious professional societies, and is a Fellow at the American Society of Colon & Rectal Surgeons, the American College of Surgeons and the Society of Surgical Oncology.After graduating summa cum laude from the University of Pennsylvania, Dr. Milsom received his medical degree from the University of Pittsburgh in 1979. He fulfilled two years of residency at Roosevelt Hospital in New York and completed his residency at the University of Virginia Medical Center, where he served as Chief Resident. He concluded his advanced training as a Fellow in Colon and Rectal Surgery at the Ferguson Clinic, Grand Rapids, Michigan in 1985, and has been a board certified colon and rectal surgeon since 1986. He joined the faculty of New York Presbyterian-Weill Cornell Medical Center in 2001.Dr. Milsom was Assistant Professor of Surgery at Michigan State University in East Lansing, Michigan from 1986 through 1989. During this period he was also the Director, Department of Surgical Research at the Ferguson Clinic. From 1990 to 1998, he was the Director of Research, Department of Colorectal Surgery at the Cleveland Clinic Foundation and from 1997 through 1998 he was also the Director of Research, Minimally Invasive Surgery Center at the Cleveland Clinic. In April 1998, Dr. Milsom became a Professor of Surgery at The Mount Sinai Medical Center in New York, Chief of the Division of Colorectal Surgery and Co-Director of Minimally Invasive Surgery.Reflecting his strong interest and expertise, Dr. Milsom currently serves as an active member of the hospital's Operating Room New Technology Committee and the Minimal Access Surgical Committee. Dr. Milsom has been recruited to participate in numerous national committees, including the Laparoendoscopic Surgical Education Committee as part of the Association of Program Directors for Colon & Rectal Surgery and the Membership Committee of the Society of American Gastrointestinal Endoscopic Surgeons.He served on the Emerging Technologies Committee for the American Society of Colon & Rectal Surgeons. Dr. Milsom is also a senior examiner for the American Board of Colon and Rectal Surgeons. He is a reviewer for Surgical Endoscopy, Diseases of the Colon & Rectum, Annals of Surgery and serves as a senior editor of WebSurg.PubMed

I am a surgical breast oncologist and am dedicated to helping patients fight breast cancer. This effort requires a team approach involving the expertise of multiple cancer specialists as well as the perspectives of the individual patient and her/his support network. We have made exciting advances in breast cancer management resulting in successful outcomes for the majority of our patients, but ongoing progress is necessary. Working together, we can provide more options to our patients and improve access to highest-quality, personalized care throughout metropolitan New York.

I am a board-certified general surgeon and surgical oncologist with a clinical expertise in melanoma and soft tissue sarcoma. I work closely with the patient and the comprehensive team of physicians to customize treatment plans for each individual. In my research, I am investigating new ways to allow the immune system to fight cancer. I am also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. I am fluent in both Spanish and English.

"What we hope to do is assemble a world class medical and research team that can provide our patients with first rate medical care and bring them the most advanced treatments."

I am a surgical oncologist whose primary area of clinical and research interest is melanoma. In 1991, I introduced lymph-node mapping and sentinel lymph-node biopsy for melanoma and other selected skin cancers. Together, these procedures can determine during surgery whether a tumor has spread to surrounding lymph nodes. Using lymph node mapping, we can pinpoint the precise lymph node into which a nearby tumor is likely to travel first (called the sentinel node). If a biopsy of the sentinel node indicates cancer spread, the surrounding lymph nodes are removed. But if there is no evidence of cancer in the sentinel node, patients are spared from additional lymph node surgery. My research has focused primarily on detecting and defining the clinical significance of individual melanoma cells in the sentinel lymph nodes, blood, and bone marrow of melanoma patients, with the goal of identifying patients at highest risk of cancer recurrence following surgery to remove a melanoma. I served as Chief of the Gastric and Mixed Tumor Service in MSKCC's Department of Surgery from 1997 until October 2003. This service focuses primarily on the surgical management of less common malignancies, including melanoma, sarcoma, gastric cancer, and pancreatic cancer, and also provides surgical support for the Lymphoma Service. I currently serve as a co-leader of the MSKCC Melanoma Disease Management Team -- a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of melanoma. On a national and international level, I am involved in advancing new ways to diagnose and treat melanoma as a member of the American Joint Commission on Cancer Melanoma Staging Committee, the National Comprehensive Cancer Network Melanoma Advisory Group, the American College of Surgeons Commission on Cancer Melanoma Working Group, the American College of Surgeons Oncology Group's Melanoma Working Group, and the World Health Organization Melanoma Committee. In addition to my interest in melanoma, I also have an expertise in the treatment of gastric cancer. I served on the program committee of the International Gastric Cancer National Meeting in 2001. And in 2002, I was co-leader of the Gastric Cancer Working Group of the National Cancer Institute's Stomach Cancer Progress Review Group. I am currently the co-principal investigator of two gastric cancer studies at MSKCC. The first evaluates the effectiveness of chemotherapy prior to surgery in high-risk gastric cancer patients, and the second is a 'Quality of Life Assessment' of gastric cancer patients. I am also an active member of the American College of Surgeons Oncology Group Upper GI Cancer Working Group. MSKCC plays a key role in training oncology doctors, and I have had a long-standing interest in the training of surgical oncology fellows. I served as the Director of Surgical Education for the Surgical Oncology Fellowship Training Program at MSKCC from 1991 to 1997, and I was Director of the Society of Surgical Oncology Training Committee, where I oversaw the administration of all surgical oncology fellowships across the nation from 1994 to 1999. As part of my interest in spreading information we have learned about cancer at MSKCC, I have lectured extensively, both nationally and internationally, and authored a number of manuscripts and reviews on various surgical oncology topics. You can view a complete listing of my publications in PubMed by clicking on the PubMed icon to the right.

I am a head and neck surgeon who has served on the faculty at Memorial Sloan-Kettering Cancer Center for more than a decade. I have a particular expertise and interest in the surgical removal of thyroid cancer, nodal metastases from thyroid cancer, and recurrent thyroid cancer. I also have a strong interest in treating oral cancer, parotid tumors, melanoma, sinus cancers, and parathyroid adenomas.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.

My surgical practice and clinical research focus entirely on the treatment of breast cancer. My research interests have included patterns of loco-regional spread, long-term outcomes of breast cancer surgery, the impact of screening mammography and, most recently, sentinel lymph node biopsy. This procedure involves removing the first few lymph nodes draining from the breast ('sentinel nodes'), and checking for the presence of cancer. If the sentinel nodes are cancer free, then the remaining nodes don't need to be removed and the side effects of the surgery are minimized. I am currently the principal investigator of MSKCC's sentinel-node biopsy program, which has the world's largest experience with this exciting new operation. My colleagues and I continue to study and refine the procedure. We have presented and published our work worldwide and have taught the procedure to hundreds of practicing surgeons and trainees. I lecture widely and am the editor of a new multi-author textbook on sentinel-node biopsy.

John Sfakianos is a caring and experienced urologist serving the communities of New York and Astoria, NY. Dr. Sfakianos attended medical school at the State University of New York in Buffalo, NY. He completed his residency in urology and internship in general surgery at the State University of New York, Downstate Medical Center. He finished a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center. He also holds a bachelor's degree from the City University of New York. Dr. Sfakianos is a member of the American Urological Association. Because he is bilingual in English and Greek, patients from a variety of backgrounds enjoy having him as their physician. Dr. Sfakianos is devoted to ensuring the longevity of his patients' health and developing long-lasting relationships with them. He takes his time to understand symptoms and give correct diagnoses to ensure the continued health of all his patients.

Dr. Kutler is a well-known Otolaryngologist-- Head and Neck Surgeon. His clinical expertise lies in the diagnosis and medical or surgical treatment of benign and malignant tumors of the head and neck, including salivary glands, thyroid and parathyroid, tongue, lips and oral cavity, larynx, pharynx, sinuses, skull base and skin. Dr. Kutler serves as the Director of the Head and Neck Surgery Division in the Department of Otolaryngology at New York Presbyterian Hospital/Weill Cornell Medical Center.Dr. Kutler received his undergraduate degree from the University of Pennsylvania, and his MD from Cornell University Medical College. Following a residency in Otolaryngology - Head & Neck Surgery at Northwestern University Medical Center, Dr. Kutler pursued additional fellowship training in Head and Neck Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He joins Weill Cornell from New York University Medical Center, where he was Assistant Professor and Chief of Otolaryngology-Head and Neck Surgery at the New York Harbor VA Medical Center. Dr. Kutler is a frequent speaker at national meetings and he has received grant funding for his research in squamous cell carcinoma of the head and neck.Dr. Kutler is a member of the American Academy of Otolaryngology - Head and Neck Surgery, the American Head and Neck Society, the New York Head and Neck Society, the American Society of Clinical Oncology, and the American Association for Cancer Research. He has received many honors, including the Merit Award from the American Society of Clinical Oncology, and the Chair's Award for Excellence in Clinical Research at Memorial Sloan-Kettering Cancer Center.